Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Thomas Meade
Другие языки:

    Thomas Meade

    Подписчиков: 0, рейтинг: 0

    Thomas Meade

    Born
    Thomas Wilson Meade

    (1936-01-21)21 January 1936
    Died 24 October 2022(2022-10-24) (aged 86)
    London
    Nationality British
    Alma mater
    Spouse Elizabeth Meade (née Perks)
    Children Richard David Meade, Helen Anna Meade, Rebecca Meade.
    Parent(s) James Edward Meade, Margaret Elizabeth Meade (née Wilson).
    Awards Balzan Prize for Epidemiology

    Thomas Wilson Meade CBE FRS FRCP (21 January 1936 – 24 October 2022) was a British epidemiologist. He was a pioneer in epidemiology—in particular, in the role blood clotting factors have in cardiovascular disease.

    Meade underwent medical training at Christ Church, Oxford, and afterwards at St Bartholomew's Hospital, qualifying in 1960.

    In 1970, after a period studying at the Schieffelin Leprosy Research Sanatorium in South India, he became Director of the Medical Research Council's Epidemiology and Medical Care Unit. He retired from there in 2001, and became Emeritus Professor of Epidemiology at the London School of Hygiene & Tropical Medicine, investigating cardiovascular disease.

    Meade held Honorary Consultant positions in Epidemiology at St Bartholomew's, and at Northwick Park Hospital.

    Meade was made a Commander of the Order of the British Empire (CBE) in the 1994 Birthday Honours "For services to Medicine and to Science", elected a Fellow of the Royal Society in 1996 and received the Balzan Prize for epidemiology in 1997.

    Tom Meade was a Quaker, attending Hampstead Friends Meeting. He had a son and two daughters, and eight grandchildren. Meade's son, Sir Richard Meade, was appointed a High Court judge in 2020. One of his daughters runs the Railway Land Wildlife Trust in Lewes, Sussex, the other is a NHS medical doctor in London.

    Meade died on 24 October 2022, at the age of 86.

    External links



    Новое сообщение